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Background: Carotid endarterectomy (CEA) has been shown to be superior to medical therapy alone in the prevention of
stroke only if it can be safely performed (ie, with a complication rate less than 3% in asymptomatic patients and less than
6% in symptomatic patients). Technical defects are the most common cause of neurological complications after CEA, and
their correction has traditionally been performed through standard surgical techniques.
Methods: From 1999, we started to treat intimal flaps, dissection, or partial thrombosis after CEA with carotid artery
stenting (CAS). A retrospective analysis of the operating room registry and of the registry of our Interventional
Cardiology laboratory was conducted in order to identify all the patients that underwent stenting of the internal carotid
artery after CEA between January 2001 and June 2009.
Results: During the time period considered, 5012 CEA were performed at our institution and a total of 34 patients
(34/5012; 0.6%) were found to have received carotid stenting after CEA, both for symptomatic and asymptomatic
defects. Immediate technical success was obtained in all patients. One major cerebrovascular adverse event (1/34; 3%) in
the immediate perioperative period was recorded. At a mean follow-up of 18.6 months (range, 3-84 months; median, 12
months), we did not observe any neurological symptoms related to the treated carotid artery, nor hemodynamic in-stent
restenosis. Long-term follow-up (ie, equal or greater than 4 years) was available for five patients: all patients remained
event-free during the entire period.
Conclusions:Our study adds to the assumption that CAS in post-CEA symptomatic and asymptomatic patients is safe and
technically feasible, and represents a valid and quick alternative to standard surgical revision. Even if in a small group of
patients, long-term results seem promising. (J Vasc Surg 2010;52:1511-7.)Carotid endarterectomy (CEA) has been shown in the
early 1990s as superior to medical therapy in the prevention
of stroke due to carotid bifurcation atherosclerosis. Five
randomized trials have demonstrated that CEA is safe and
effective in the prevention of stroke for both asymptomatic
and asymptomatic patients, provided that they have a high-
grade carotid stenosis.1-5
Consistent with these findings, these trials have also proved
that CEA is effective in the prevention of stroke only if it can be
safely performed (ie, the center shows a rate of perioperative
neurological complications lower than the riskof strokeborneby
the stenosis).2,5 Most of the guidelines on the use of CEA in
patientswith carotid disease state that carotid endarterectomy, to
be effective, should be performed in centers that can achieve a
complication rate smaller than 3% in asymptomatic patients and
less than 6% in symptomatic ones.6-8
The analysis of series of patients undergoing CEA has
recognized technical defects at the end of endarterectomy
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doi:10.1016/j.jvs.2010.06.167as the most common cause of early neurological complica-
tions.9,10Moreover, other authors have shown that emergent
correction of post-endarterectomy defects causing neurologic
symptoms is mandatory to reduce further deterioration and
maximize salvage of neurologic functions.11-13
Consistent with these findings, many surgeons perform an
intraoperative quality check at the end of CEA in order to assess
and correct any residual defect before it might cause ischemic
neurologic deficits.14-16 Themost commonmethods are duplex
scanor angiography,10 even thoughno randomized studyhas so
far demonstrated that intraoperative check really reduces the
incidence of neurological complications after CEA.
In the past years, we achieved correction of residual
defects or stenosis with surgical techniques comprising
resection and bypass grafting or distal arteriotomy on the
internal carotid artery (ICA) and patch closure. From
1999, we started to treat intimal flaps, dissection, or partial
carotid thrombosis with carotid artery stenting (CAS)
when the risk of surgical revision was considered to be too
high.17 Since 2005, CAS has become our treatment of choice
when immediate revisional surgery is considered at high op-
erating risk. The risk pertains to the technical challenge of
extensive distal carotid dissection, with possible cranial nerve
lesions, and to the risk of cerebral ischemia related to pro-
longed clamping time and shunt manipulation.18
We hereby report our experience and analyze the re-
sults of CAS in the treatment of post-CEA defects, both
symptomatic and asymptomatic.
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Patient demographics and indication for treatment.
A retrospective analysis of the operating room registry and
of the registry of our Interventional Cardiology laboratory
was conducted in order to identify all the patients that
underwent stenting of the internal carotid artery after CEA.
The time interval considered was between January 2001
and June 2009. During this period, 5012 CEAs were
performed at our Institution, and a total of 34 patients
(34/5012; 0.6%) were found to have received carotid
stenting after CEA. Patients’ demographic data are summa-
rized in Table I.
Presenting symptoms for CEA were a previous ipsilat-
eral stroke in two cases, ipsilateral episode of amaurosis
fugax in two cases, and ipsilateral transient ischemic attack
in two cases. Twenty-eight patients were asymptomatic. All
lesions were atherosclerotic in etiology, and no patients
presented with a restenosis.
The degree of stenosis was determined by duplex scan-
ning, conducted in our noninvasive vascular laboratory,
which was performed in all cases (34/34; 100%) and that
represents our sole preoperative study in the majority of
patients.19 Six patients were also studied by magnetic res-
onance angiography (MRA; three patients) or computed
tomography angiography (CTA; three patients). CTA/
MRA is always performed in patients considered for pri-
mary CAS, in patients presenting with a recent neuroisch-
emic event, in cases of suspected “string sign” lesions/near
occlusion, and when duplex scanning is not conclusive.
Indications for surgery were given in accordance with
the findings of the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) and with the Asymptom-
atic Carotid Atherosclerosis Study trial.2,3
Carotid endarterectomy technique. All CEA were
conducted under cervical block anesthesia. Intravenous
heparin was administered (70 IU/kg) in order to obtain an
activated clotting time greater than 200 seconds through-
out the procedure. At declamping, half the dose of prota-
mine sulfate required to antagonize all heparin was admin-
istered.
CEA was performed in five cases (5/34; 15%) using
standard endarterectomy and patch closure; in all five cases
(5/5; 100%) shunting was necessary due to clamping intol-
erance (ie, alteration of the neurological status determined
by clinical monitoring performed by room anesthesiolo-
gist). In 29 cases (29/34; 85%), the eversion technique was
Table I. Patients’ demographics
Value
Age (Mean) 70 (44-86)
Females 11 (32%)
Diabetes mellitus 9 (26%)
Hypertension 29 (85%)
Dislipidemia 20 (59%)
History of smoking habits 15 (44%)used. Shunting was selectively performed in two cases(2/29; 7%), due to late clamping intolerance (7 and 9
minutes, respectively, after the beginning of the endarter-
ectomy). It is our common practice to perform standard
CEA when the patient shows clamp intolerance, while
eversion CEA is preferred when the patient tolerates clamp-
ing.
We routinely perform carotid angiography to assess the
result of the endarterectomy in all cases for eversion endar-
terectomy and in selective cases after standard endarterec-
tomy. Indications for angiography after standard CEA are a
specific concern regarding the technical outcome by the
surgeon and/or the use of tacking sutures to secure the
distal end point. Arteriography is conducted through direct
puncture of the common carotid artery (CCA), far from the
end point of the endarterectomy, with a 21 G needle.
Indication for post-CEA stenting and stenting
technique. The main indication for post-CEA stenting
was the detection at angiography of a defect in the endar-
terectomized internal carotid artery, which could not be
safely treated through surgical revision. The risk of revision
was augmented due to clinical (ie, clamping intolerance
during endarterectomy) or anatomical factors (ie, defect of
the distal end point, with the need to proceed with exten-
sive cephalad exposure of the internal carotid artery [ICA]).
Patients that, according to the treating surgeon, did not
show high risk features (ie, well-tolerated clamping and had
an easily accessible defect) were managed with revisional
surgery (15 patients).
Post-CEA defects were classified as either asymptom-
atic, when their detection was by means of angiography,
and they did not cause any neurological impairment, or
symptomatic, when the patients developed neurological
complications after CEA, and the angiographic study
showed a compatible defect of the endarterectomy site.
The defects were also subgrouped according to their
angiographic characteristics. These included: distal/proxi-
mal intimal flap, residual distal stenosis, partial thrombosis
of the endarterectomy site with/without an intimal flap/
residual stenosis, distal ICA spasm, and extreme angulation
of the distal ICA after CEA.
Asymptomatic residual stenoses were treated if equal or
greater than 50% (NASCET method). Distal and proximal
intimal flaps were treated when clearly recognizable at
angiography. Although proximal flaps are considered to
remodel with time by some authors,15,20 we feel safer to
also treat this lesion when recognized at angiography
to prevent possible local thrombosis.
Symptomatic defects were always considered an indica-
tion for treatment, in spite of their size. The presence of
recognizable partial thrombosis also always mandated for
correction as the risk of an embolic event was assumed to be
consistent in this setting.
All the patients whose defect did not meet the afore-
mentioned criteria were managed conservatively.
Twenty-seven patients were shown to have an asymp-
tomatic defect in the treated ICA at completion angiogra-
phy, while in seven cases, stenting was performed in pa-
tients that had a symptomatic post-CEA defect. These
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in the recovery room or in the surgical ward.
The type of lesion and its occurrence in the symptom-
atic/asymptomatic group are reported in Table II.
The decision to proceed to stenting in symptomatic
lesions was based on three factors:
- Duplex scanning of the ICA did not show complete
thrombosis and was not conclusive for the demon-
stration of any residual defect amenable to surgical
revision;
- selective carotid angiography was deemed necessary
as a second level exam to determine the presence and
localization of defects;
- stenting represented the fastest treatment option,
with the CathLab being the most readily available
facility.
Post-CEA stenting was performed either through a
direct transcervical approach (27/34 cases; 79%) or
through the usual transfemoral access (7/31 cases; 23%).
In both cases, additional intravenous heparin was adminis-
tered to maintain an activated clotting time200 seconds.
In the transcervical approach, a 6 to 7 F short (11 cm)
introducer sheath was placed in the common carotid artery
using the Seldinger technique and a 0.035” guidewire. The
introducer was previously advanced in the operating field
through a separate stab incision of the skin to reduce the
angle between the introducer and the common carotid
artery, as previously described by our group (Fig 1).17
Cannulation of the CCA and crossing of the lesion with the
0.014” guidewire/stent system was always made with tem-
porary clamping of the CCA and external carotid artery
(ECA) in order to reduce the risk of dislocation of debris
with distal embolization. No embolic protection device
was therefore deemed necessary with the transcervical
approach.
The traditional transfemoral approach was used when
the patients became symptomatic in the ward/recovery
room (4/7 patients; 57%), or if the final intraoperative
angiography result was not conclusive (3/7 patients; 43%).
In the latter three patients, angiography performed with
direct puncture of the CCA and the mobile C-arm did not
allow us to completely exclude or confirm the presence of a
defect. In these cases, we decided tomove the patient to the
CathLab in order to have a higher quality study, with the
ceiling mounted angiographic system (which in our insitu-
tion has a higher resolution than the available portable
Table II. Angiographic characteristics of the lesions
Intimal flap
Distal residual
stenosis Par
Symptomatic 1 0
Asymptomatic 10 14
Total 11 14
Asymptomatic residual stenoses were treated if equal or greater than 50% (N
Distal and proximal intimal flaps were treated when clearly recognizable byC-arm).In this case, angiography and stenting were performed
using standard techniques, via a 7 to 8 F long (90 cm)
introducer sheath, in a fully equipped Interventional Car-
diology laboratory. A distal embolic protection device was
used in six cases (6/7; 86%): the Angioguard (Cordis
Corporation, East Bridgewater, NJ) in three cases, the
Emboshield (Abbot Laboratories, Abbot Park, Ill) in two,
and the Epifilter system (Boston Scientific, Natick, Mass) in
one.
The decision to treat symptomatic patients in the Cath-
Lab depended mainly on two factors:
a) Duplex ultrasound performed after onset of symptoms
did not show occlusion of the ICA (in this case surgical
thrombectomy is the only option);
b) the CathLab was the facility more readily available as the
operating room was occupied by an ongoing operation.
When available, the operating room is at present our
preferred choice as it allows direct puncture of the CCA
(avoiding the possible problems with CCA cannulation)
and the option to proceed, in theory, to immediate revi-
sional surgery if stenting is not feasible.
Stent implantation was always performed using a self-
expandable stent, with the intent to cover the entire defect
hrombosis Distal spasm
Angulation of the
ICA Total
1 0 7
1 1 27
2 1 34
ET method).
st surgeon at angiography.
Fig 1. Intraoperative view of a stented carotid artery after CEA
(left). At a magnified view, the stent struts are clearly visible
through the carotid wall (right). The introducer sheath is inserted
through a separate stab incision to smooth the angle with the
common carotid artery (lower left box).tial t
5
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6or the region of haziness/thrombosis. Thirty-three patients
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tient required two stents to completely cover the lesion
(short dissection of the proximal and distal edge of the
endarterectomy). The type of and length of stents are
reported in Table III. No patient required final balloon
angioplasty.
Postoperative medical therapy was acetylsalicytic acid
(75-160 mg) associated to Clopidogrel (75 mg) for 4 to 6
weeks, and thereafter the patient continued with aspirin
alone. Clopidogrel was started in the immediate postoper-
ative period, once blood tests showed that all the coagula-
tion parameters were back to normal. Intraoperative intra-
venous acetylsalicytic acid was given only to those patients
that were not on longstanding therapy with aspirin.
RESULTS
Technical success and perioperative complications.
Immediate technical success, defined as less than 20% re-
sidual stenosis at final angiogram, was obtained in all pa-
tients (Figs 2, 3).
In symptomatic patients, the mean time elapsed from
the beginning of symptoms to stenting was less than 20
minutes with the transcervical approach. All those patients
became symptomatic at declamping or shortly thereafter
(before closure of the cervical incision). The mean time
elapsed with the transfemoral approach was 76 minutes
(range, 45-120; SD 32.5). All the symptomatic patients
treated with the transfemoral approach developed neuro-
logical impairment in the recovery room or in the ward.
We had three adverse events (3/34; 9%) in the imme-
diate perioperative period: one major neurologic adverse
event related to stent implantation (1/34; 3%) and two
bleeding complications (2/34; 6%).
One patient developed paresis of the arm in the surgical
ward after CEA and stenting for an asymptomatic flow
limiting spasm, which did not respond to conventional
Table III. Type of and length of stents used
Stent type (N, %) Length N
Wallstent (13, 37%) 6  30 2
6  40 3
7  30 1
7  40 2
8  30 1
9  30 1
9  40 2
10  30 1
Acculink (5, 14%) 6-8  40 1
7  30 1
7  40 1
7-10  40 2
Precise (16, 46%) 6  40 4
7  30 7
7  40 2
8  30 2
8  40 1
X-act (1, 3%) 7-9  40 1treatment with local vasodilators and intra-arterial nitrates.An emergent duplex scan showed complete in-stent throm-
bosis that was confirmed by angiography. The patient was
taken back to the operating room and underwent revision
with balloon embolectomy of the thrombosed stent. The
symptoms progressively ameliorated, and the patient was
discharged with only mild paresis of the left arm.
Two patients had to undergo revision of the surgical
wound due to postoperative bleeding. Accurate revision
was performed with no further complication.
Results in symptomatic patients. Technical success
was possible in all symptomatic patients, both using the
transfemoral or the transcervical approach. Two patients
out of seven (25%) experienced amelioration/complete
resolution of their initial symptoms in the postoperative
period. In five cases, symptoms persisted with minimal
amelioration throughout hospitalization and at discharge.
No patient experienced worsening of the presenting symp-
toms after stenting. Results for symptomatic patients are
Fig 2. Post-CEA angiogram showing complete occlusion of the
ICA due to a distal flap (A) and final result after stenting (B).
Fig 3. Post-CEA angiogram showing partial parietal thrombosis
of the ICA after CEA (A). Final result after stenting (B) and
intraoperative view (C).presented in Table IV.
latera
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(15%) were lost to follow-up. Five patients (15%) died of
carotid-unrelated reasons (two patients of cancer, one pa-
tient of complications of a general surgery operation, two
patients of heart attack), with no reported complications of
the vascular operation.
At a mean follow-up of 18.6 months (range, 3-84
months; median, 12months) we did not observe any stroke
or neurological symptoms related to the ipsilateral carotid
territory. No patient developed in-stent restenosis that
necessitated treatment, nor dilatation or pseudoaneurysm
of the treated carotid artery.
Long-term follow-up (ie, equal or greater than 4 years)
was available for five patients: all patients remained event-
free during the entire period.
DISCUSSION
Despite the demonstrated benefits of CEA in the pre-
vention of stroke,1-3,5 this procedure entails a potential risk
of cerebrovascular complications, and its benefit is strictly
dependent on achieving a low rate of neurological adverse
events.6-8
Even though some events are unpredictable, most of
these complications (at least 60% in some series) are caused
by technical errors made during carotid endarterectomy or
reconstruction.9,11
Many authors consider complete thrombosis or partial
thrombosis with distal embolization as the natural outcome
of these technical errors, thus implying the important role
of intraoperative quality check and early correction of both
symptomatic and asymptomatic defects.9-11,21-23 On the
Table IV. Results of post-CEA stenting in patients with s
Patient Carotid Sex Age Symptoms
1 Left ICA F 59 Weakness of right
arm
2 Right ICA M 66 Left hemiparesis 
right emiplegia
3 Right ICA M 75 Left hemiparesis
4 Left ICA F 59 Weakness of right
arm
5 Left ICA M 60 Right hemiparesis
6 Left ICA F 68 Weakness of right
arm
7 Right ICA F 73 Weakness of left
arm
, complete resolution of symptoms/frank amelioration of symptoms at
, mild amelioration.
, symptoms unchanged.
Patient 2 developed right hemiplegia due to a left ischemic stroke. Contra
occurrence, are described in literature.11other hand, other authors claim that asymptomatic defectsare rather benign and self limiting, thus requiring no cor-
rection.20,24,25 Moreover, other authors have shown that a
symptomatic post-CEA defect is still correlated to a rather
poor prognosis, even after correction,26 thus questioning
the role of revisional surgery.
Although no clear consensus exists, many surgeons
perform intraoperative quality checks and early surgical
revision of post-CEA defects. Several intraoperative imag-
ing and physiologic assessment techniques are available, the
most used being duplex ultrasonography and intraopera-
tive arteriography. The general opinion is that not every
defect seen on postoperative check is worth fixing,27 but
much controversy exists on what defect should be treated
before it becomes symptomatic. Different criteria have
been used to establish defects worth fixing detected with
angiography. Several authors claimed that intimal flaps
greater than 2 mm, luminal stenoses of more than 30%
relative to the distal ICA, any intraluminal filling defect,
spastic narrowing of 30% diameter reduction, or relevant
kinks16,28 could be considered as worth fixing even though
no controlled trial has so far been published on the out-
come of revision.
Options for revision are resection and bypass grafting of
the ICA or distal arteriotomy with fixation of distal flaps
with tacking sutures.9,11,29 It is well known that taking
down the suture and putting in tacking sutures is the easiest
way to deal with a flap, especially if the patient tolerates
reclamping. On the other hand, when the patient does not
tolerate clamping, shunting in the presence of a distal flap
can be at risk of extending the dissection more distally. In
our experience, CAS has proven especially useful in case of
omatic defect of the ICA
Type of lesion
Time to
stenting
(minutes) Brain CT
Symptoms at
discharge
al spasm 20 N/A 
al flap 20 Left and right
ischemic
lesion

ial thrombosis 20 Right
ischemic
lesion

al flap with
artial thrombosis
120 N/A 
ial thrombosis 60 Left ischemic
lesion

ial thrombosis 45 Left ischemic
lesion

ial thrombosis 
cclusion of the
CA
80 Right
ischemic
lesion

rge.
l ischemic strokes, unrelated to the operated carotid artery, though a rareympt
Dist
Dist
Part
Dist
p
Part
Part
Part
o
E
dischaclamping intolerance as it avoids the need for shunt inser-
JOURNAL OF VASCULAR SURGERY
December 20101516 Marone et altion. It is worth noting that, in our series, 19% of patients
(6/31) required shunting due to impairment of the neuro-
status during clamping.
CAS reduces the need for extensive cephalad exposure
of the ICA,29 which is often required during revisional
surgery for distal flaps. Dissection of the distal ICA can be
technically demanding and may be associated with a sub-
stantial risk of cranial nerve injury (vagus, hypoglossal,
spinal accessory, and glossopharyngeal nerve).18Moreover,
it sometimes mandates for additional maneuvers such as
temporary mandibular subluxation,30 which is not possible
with locoregional anesthesia.
Our group was the first to describe the use of stenting
for the correction of defects of the ICA after CEA, both
using the transcervical and the transfemoral approach.17
As previously reported also by other authors,18,31 our
study shows that the judicious use of stents for the correc-
tion of residual defects after CEA is technically feasible and
may entail several advantages.
The use of CAS also consistently shortens the surgical
time that is needed for revision (in our series, the time
required for transcervical stenting was 20 minutes for all
patients). This is particularly useful when using cervical
block anesthesia that is associated to a finite period of
analgesia.31
Embolic protection devices (EPDs) were used in six of
31 cases (19%). EPDs were never used with the transcervi-
cal approach but were used in six of seven cases (86%) of
transfemoral approach. The decision whether to use or not
an EPD device was left to the operator and depended
primarily on what was detected at angiography; as a matter
of fact, the atheromatous plaque had already been removed
at the time of stenting, thus reducing the known benefit
related to EPDs.17,31
The rationale that directed the choice was the inherent
risk of distal embolization related to the lesion. EPDs were
used in the presence of partial thrombosis of the endarter-
ectomy site, demonstrated by the presence of haziness at
angiography. If the defect detected was a flap or residual
stenosis of the distal end point EPDs was not used, because
the embolic risk was rather low.
We also evaluated the utility of emergent CAS for the
treatment of symptomatic post-CEA defects. In accordance
with a previous work published with Anzuini et al,32 our
study showed that no patients experienced worsening of
neurologic symptoms after CAS, and that two patients had
a substantial amelioration of their symptoms (Table IV). In
this specific case, the use of EPDs is strongly advisable as the
majority of symptomatic defects are thrombotic in etiology
and thus have a high embolic risk.10
Even though the numbers are small, our study adds to
the assumption that CAS in post-CEA symptomatic pa-
tients is safe and technically feasible. We believe that it
represents a valid alternative to standard surgical revision, as
it can be performed quickly (20 minutes with the tran-
scervical approach, 76 32.5 minutes with the transfemo-
ral approach) and effectively.We experienced three major adverse events. One (1/
31; 3%) patient experienced complete in-stent thrombosis
with contralateral arm paresis, after stenting for a flow-
limiting asymptomatic distal spasm. He was treated
through mechanical thrombectomy with restoration of
normal flow and had complete resolution of symptoms at
discharge. The pathologic mechanism at the base of this
event remains highly speculative, as both a distal spasm at
the cranial edge of stent or a delay in the administration of
Clopidogrel might have played a role.
We also had two patients that had to undergo revision
of the surgical site for bleeding. Even though the use of
double antiplatelet therapy is associated with a higher risk
of bleeding during surgery,33 we believe that the cause is
not antiplatelet therapy alone and that meticulous hemo-
stasis might avoid bleeding problems even in patients that
need double antiplatelet therapy.
At present, long-term follow-up data for wide sets of
patients are still unavailable, even though mid-term data
seem rather promising, with Ross et al and Tameo et al
reporting a stroke and reintervention-free mean follow-up
of 15 and 18 months, respectively.18,31
In our study, we report long-term follow-up for a small
group of patients treated with stenting after CEA, with no
complication or reintervention related to the treated ca-
rotid artery.
The costs associated with this technique (mainly the
costs of stents and EPDs) remain a major and not yet
solvable problem, even if these costs could be compared
against a shorter occupation of the operating room and
against all the eventual resources spent to treat complica-
tions of distal ICA exposure, such as cranial nerve injury.18
We consider CAS as a valuable alternative to surgical
revision, both for symptomatic and asymptomatic post-
CEA defects. In our experience, this technique represents a
simple and expeditious way to solve an often demanding
surgical problem, such as the correction of residual defects
after CEA. Nevertheless, this procedure is not risk-free, as
we experienced a major procedure-related adverse event
that fortunately resolved.
Our study entails some specific limitations. First of all, it
is a retrospective analysis, with all its specific limitations, in
particular considering the follow-up, which was available
only in 85% of patients.
The cornerstone of surgical treatment of extracranial
carotid stenosis remains a low perioperative complication
rate, and post-CEA CAS represents an additional means to
achieve this goal. We believe that a better understanding of
the pathologic mechanism at the base of post-CEA strokes
and of the behavior of post-CEA defects is yet mandatory.
This could allow the treatment of only the patients that
might really benefit from CAS, thus reducing costs and
nullify possible CAS related complications.
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